Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05919901
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-26
First Post:
2023-06-12
Brief Title:
Multi-level School-based Intervention to Improve HPV Vaccine Uptake and Completion in South Africa
Sponsor:
Brigham and Womens Hospital
Organization:
Brigham and Womens Hospital
Study Overview
Official Title:
Multi-level School-based Intervention to Improve HPV Vaccine Uptake and Completion in South Africa
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Human Papillomavirus HPV is the most common sexually transmitted infection globally and is causally linked to cervical anogenital and oropharyngeal cancers HPV-associated cancers have a disproportionate impact in low-resource settings and nowhere is this evident than in South Africa which has a uniquely vulnerable population due to the convergence of the largest HIV epidemic globally with HPV rates of up to 85 in young women under the age of 25 For the clinical trial phase of this study we intend to evaluate preliminary effects of a communications strategy and key criteria to advance to a full scale hybrid type 2 trial Our systems-focused approach leverages established partnerships with area schools serving diverse populations who are not always effectively served by traditional healthcare channels
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None